AWM Investment Company’s Cellectar Biosciences CLRB Stock Holding History

AWM Investment Company’s Portfolio CLRB Stock Details CLRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-355	Closed	-$5K	–	89
2019 Q2	$5K	Hold	355	–	–	﹤0.01%	91
2019 Q1	$11K	Hold	355	–	–	﹤0.01%	84
2018 Q4	$5K	Hold	355	–	–	﹤0.01%	85
2018 Q3	$9K	Buy	355 +319	+886%	+$376K	﹤0.01%	88
2018 Q2	$19K	Hold	36	–	–	﹤0.01%	90
2018 Q1	$13K	Hold	36	–	–	﹤0.01%	90
2017 Q4	$11K	Hold	36	–	–	﹤0.01%	94
2017 Q3	$17K	Buy	+36	New	+$174K	﹤0.01%	88
2017 Q2	–	Sell	-36	Closed	-$41K	–	94
2017 Q1	$41K	Hold	36	–	–	0.01%	95
2016 Q4	$19K	Hold	36	–	–	﹤0.01%	100
2016 Q3	$27K	Hold	36	–	–	﹤0.01%	99
2016 Q2	$47K	Hold	36	–	–	0.01%	96
2016 Q1	$77K	Hold	36	–	–	0.02%	93
2015 Q4	$595K	Sell	36 -37	-51%	-$1.57M	0.12%	84
2015 Q3	$3.1M	Sell	73 -1	-1%	-$91K	0.6%	48
2015 Q2	$4.12M	Hold	74	–	–	0.59%	55
2015 Q1	$4.38M	Hold	74	–	–	0.61%	59
2014 Q4	$4.38M	Buy	+74	New	+$5.7M	0.6%	56

Other funds holding CLRB

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

AWM Investment Company's CLRB Position: Q3 2019 in Review

AWM Investment Company sold out of Cellectar Biosciences (CLRB) in Q3 2019, closing a stake of 355 shares — an estimated $5K sold.

AWM Investment Company first reported a position in CLRB in Q4 2014 and held it in 18 quarters. The position peaked at $4.38M in Q1 2015. 12 funds tracked by Wall St. Rank hold CLRB as of Q3 2019.

AWM Investment Company reported no remaining Cellectar Biosciences position as of Q3 2019 after selling out during the quarter.
AWM Investment Company sold 355 Cellectar Biosciences shares in Q3 2019, an estimated $5K.
AWM Investment Company first reported a position in Cellectar Biosciences in Q4 2014 and held it in 18 quarters.
AWM Investment Company's Cellectar Biosciences position peaked at $4.38M in Q1 2015.
12 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2019.

Based on AWM Investment Company's 13F filing for Q3 2019, filed 12 Nov 2019.